SUBSCRIBE
SUBSCRIBE

enVVeno Medical

IN THE PRESS
Press Releases
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)
August 20, 2025
 · 
4 min read
Press Releases
enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 18, 2025
 · 
2 min read
Press Releases
Health Economic Study Shows That enVVeno Medical’s VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency
August 7, 2025
 · 
7 min read
Press Releases
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 4, 2025
 · 
5 min read
Press Releases
Positive Interim 2-Year Data from enVVeno Medical’s VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
June 9, 2025
 · 
6 min read
Press Releases
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
May 20, 2025
 · 
5 min read
Press Releases
enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24
May 1, 2025
 · 
5 min read
Press Releases
VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium
April 23, 2025
 · 
3 min read
Press Releases
The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium
April 1, 2025
 · 
4 min read
Press Releases
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
March 3, 2025
 · 
6 min read
Load More
JOBS